Immunochemically unreactive albumin in urine: Fiction or reality?

Critical Reviews in Clinical Laboratory Sciences

Volumn 48, Issue 2, 2011, Pages 87-96

  Speeckaert, Marijn M ^a   Speeckaert, Reinhart ^a   Van De Voorde, Lien ^a   Delanghe, Joris R ^a  

^a GHENT UNIVERSITY   (Belgium)

Author keywords

Albumin fragmentation; Assays; Immunochemically unreactive albumin

Indexed keywords

ALBUMIN; ALBUMIN ANTIBODY; PEPTIDE FRAGMENT; PROTEIN KINASE;

ALBUMINURIA; BURN; CARDIOVASCULAR DISEASE; CROHN DISEASE; DIABETES MELLITUS; GEL PERMEATION CHROMATOGRAPHY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; IMMUNOASSAY; IMMUNOCHEMISTRY; IMMUNOREACTIVITY; KIDNEY FAILURE; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; NEPHROTIC SYNDROME; NONHUMAN; OXIDATIVE STRESS; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN DEGRADATION; RADIOIMMUNOASSAY; REVIEW; SILVER STAINING; STANDARDIZATION; TANDEM MASS SPECTROMETRY; URINALYSIS; URINARY TRACT;

ALBUMINS; ALBUMINURIA; HUMANS; IMMUNOASSAY; URINALYSIS;

EID: 80052141780     PISSN: 10408363     EISSN: 1549781X     Source Type: Journal    
DOI: 10.3109/10408363.2011.591366     Document Type: Review

References (88)

1. Bigazzi R, Bianchi S, Baldari D, Campese VM. Microalbuminuria predicts cardiovascular events and renal insufficiency in patients with essential hypertension. j Hypertens 1998;16:1325-1333. (Pubitemid 28408416)
2. Mogensen CE. Microalbuminuria, blood pressure and diabetic renal disease: origin and development of ideas. Diabetologia 1999;42:263-285. (Pubitemid 29111432)
3. Arnlöv J, Evans JC, Meigs JB, Wang TJ, Fox CS, Levy D et al. Lowgrade albuminuria and incidence of cardiovascular disease events in nonhypertensive and nondiabetic individuals: the Framingham Heart Study. Circulation 2005;112:969-975. (Pubitemid 41170264)
4. Xu J, Knowler WC, Devereux RB, Yeh J, Umans JG, Begum M et al. Albuminuria within the "normal" range and risk of cardiovascular disease and death in American Indians: the Strong Heart Study. Am j Kidney Dis 2007;49:208-216. (Pubitemid 46178394)
5. Comper WD, Osicka TM, Jerums G. High prevalence of immunounreactive intact albumin in urine of diabetic patients. Am j Kidney Dis 2003;41:336-342. (Pubitemid 36152451)
6. Yagame M, Suzuki D, Jinde K, Yano N, Naka R, Abe Y et al. Urinary albumin fragments as a new clinical parameter for the early detection of diabetic nephropathy. Intern Med 1995;34:463-468.
7. Myers BD. Pathophysiology of proteinuria in diabetic glomerular disease. j Hypertens Suppl 1990;8:S41-S46. (Pubitemid 20283837)
8. Miller WG, Bruns DE, Hortin GL, Sandberg S, Aakre KM, McQueen MJ et al.; National Kidney Disease Education Program-IFCC Working Group on Standardization of Albumin in Urine. Current issues in measurement and reporting of urinary albumin excretion. Clin Chem 2009;55:24-38.
9. Donadio E, Piccolomini F, Dimuccio V, Felicioli A, Balestreri E, Cianti R et al. Serum albumin fragmentation in end-stage renal disease patients-a pilot study. Clin Chem Lab Med 2009;47:1373-1379.
10. Seegmiller JC, Sviridov D, Larson TS, Borland TM, Hortin GL, Lieske JC. Comparison of urinary albumin quantification by immunoturbidimetry, competitive immunoassay, and proteincleavage liquid chromatography-tandem mass spectrometry. Clin Chem 2009;55:1991-1994.
11. Sviridov D, Drake SK, Hortin GL. Reactivity of urinary albumin (microalbumin) assays with fragmented or modified albumin. Clin Chem 2008;54:61-68. (Pubitemid 351182597)
12. Sviridov D, Hortin GL. Urine albumin measurement: effects of urine matrix constituents. Clin Chim Acta 2009;404:140-143.
13. Osicka TM, Panagiotopoulos S, Jerums G, Comper WD. Fractional clearance of albumin is influenced by its degradation during renal passage. Clin Sci 1997;93:557-564. (Pubitemid 27517290)
14. Osicka TM, Comper WD. Protein degradation during renal passage in normal kidneys is inhibited in experimental albuminuria. Clin Sci 1997;93:65-72. (Pubitemid 27313383)
15. Osicka TM, Houlihan CA, Chan JG, Jerums G, Comper WD. Albuminuria in patients with type 1 diabetes is directly linked to changes in the lysosome-mediated degradation of albumin during renal passage. Diabetes 2000;49:1579-1584.
16. Nakayama A, Sakatsume M, Kasama T, Kawara T, Gejyo F, Isobe M et al. Molecular heterogeneity of urinary albumin in glomerulonephritis: comparison of cardiovascular disease with albuminuria. Clin Chim Acta 2009;402:94-101.
17. Norden AG, Sharratt P, Cutillas PR, Cramer R, Gardner SC, Unwin RJ. Quantitative amino acid and proteomic analysis: very low excretion of polypeptides 〉750 Da in normal urine. Kidney Int 2004;66:1994-2003.
18. Hilliard LM, Osicka TM, Clavant SP, Robinson PJ, Nikolic-Paterson DJ, Comper WD. Characterization of the urinary albumin degradation pathway in the isolated perfused rat kidney. j Lab Clin Med 2006;147:36-44. (Pubitemid 43144921)
19. Peters H. All about albumin: biochemistry, genetics, and medical applications. San Diego, CA: Academic Press, 1996.
20. Iwao Y, Hiraike M, Kragh-Hansen U, Mera K, Noguchi T, Anraku M et al. Changes of net charge and alpha-helical content affect the pharmacokinetic properties of human serum albumin. Biochim Biophys Acta 2007;1774:1582-1590. (Pubitemid 350235344)
21. Wiggins RC, Kshrisagar B, Kelsch RC, Wilson BS. Fragmentation and polymeric complexes of albumin in human urine. Clin Chim Acta 1985;149:155-163. (Pubitemid 15030860)
22. Calzada-García JA, Pérez González MN, Benito-Andrés FJ, Morales García LJ, Cabezas JA, Sánchez-Bernal C. Evaluation of patterns of urinary proteins by SDS-PAGE in rats of different ages. Mech Ageing Dev 1996;87:1-13. (Pubitemid 26142426)
23. Candiano G, Musante L, Bruschi M, Petretto A, Santucci L, Del Boccio P et al. Repetitive fragmentation products of albumin and alpha1-antitrypsin in glomerular diseases associated with nephrotic syndrome. J Am Soc Nephrol 2006;17:3139-3148. (Pubitemid 44707774)
24. Maunsbach AB. Absorption of I-125-labeled homologous albumin by rat kidney proximal tubule cells. A study of microperfused single proximal tubules by electron microscopic autoradiography and histochemistry. J Ultrastruct Res 1966;15:197-241.
25. Christensen EI, Nielsen S, Moestrup SK, Borre C, Maunsbach AB, de Heer E et al. Segmental distribution of the endocytosis receptor gp330 in renal proximal tubules. Eur J Cell Biol 1995;66:349-364.
26. Kshirsagar B, Wilson B, Wiggins RC. Polymeric complexes and fragments of albumin in normal human plasma. Clin Chim Acta 1984;143:265-273. (Pubitemid 15218089)
27. Burne MJ, Panagiotopoulos S, Jerums G, Comper WD. Alterations in renal degradation of albumin in early experimental diabetes in the rat: a new factor in the mechanism of albuminuria. Clin Sci 1998;95:67-72. (Pubitemid 28370580)
28. Osicka TM, Yu Y, Panagiotopoulos S, Clavant SP, Kiriazis Z, Pike RN et al. Prevention of albuminuria by aminoguanidine or ramipril in streptozotocin-induced diabetic rats is associated with the normalization of glomerular protein kinase C. Diabetes 2000;49:87-93. (Pubitemid 30022928)
29. Olbricht CJ, Geissinger B. Renal hypertrophy in streptozotocin diabetic rats: role of proteolytic lysosomal enzymes. Kidney Int 1992;41:966-972.
30. Myers BD, Winetz JA, Chui F, Michaels AS. Mechanisms of proteinuria in diabetic nephropathy: a study of glomerular barrier function. Kidney Int 1982;21:633-641. (Pubitemid 12156924)
31. Scandling JD, Black VM, Deen WM, Myers BD. Glomerular permselectivity in healthy and nephrotic humans. Adv Nephrol Necker Hosp 1992;21:159-176.
32. Gekle M, Mildenberger S, Freudinger R, Schwerdt G, Silbernagl S. Albumin endocytosis in OK cells: dependence on actin and microtubules and regulation by protein kinases. Am J Physiol 1997;272:F668-F677.
33. Koya D, Lee IK, Ishii H, Kanoh H, King GL. Prevention of glomerular dysfunction in diabetic rats by treatment with d-alpha-tocopherol. J Am Soc Nephrol 1997;8:426-435. (Pubitemid 127454178)
34. Derubertis FR, Craven PA. Activation of protein kinase C in glomerular cells in diabetes. Mechanisms and potential links to the pathogenesis of diabetic glomerulopathy. Diabetes 1994;43: 1-8.
35. Han HJ, Koh HJ, Park SH. A signaling pathway for stimulation of Na+ uptake induced by angiotensin II in primary cultured rabbit renal proximal tubule cells. J Vet Med Sci 1999;61:135-141. (Pubitemid 129620032)
36. Radons J, Biewusch U, Grässel S, Geuze HJ, Hasilik A. Distinctive inhibition of the lysosomal targeting of lysozyme and cathepsin D by drugs affecting pH gradients and protein kinase C. Biochem J 1994;302 (Pt 2):581-586. (Pubitemid 24280116)
37. Gewert K, Tapper H, Nauclér C, Sundler R. Dexamethasone downregulates lysosomal secretion in mouse macrophages: involvement of signaling through protein kinase C. J Inflamm 1995;47:115-125. (Pubitemid 27057414)
38. Hilliard LM, Russo LM, Comper WD. Hypertension-mediated albuminuria is associated with reduced lysosomal activity in the kidney and the heart. Am J Nephrol 2009;29:454-464.
39. Russo LM, Comper WD, Osicka TM. Mechanism of albuminuria associated with cardiovascular disease and kidney disease. Kidney Int Suppl 2004;92:S67-S68. (Pubitemid 43361436)
40. Russo LM, Osicka TM, Brammar GC, Candido R, Jerums G, Comper WD. Renal processing of albumin in diabetes and hypertension in rats: possible role of TGF-beta1. Am J Nephrol 2003;23:61-70. (Pubitemid 36164598)
41. Russo LM, Brammar GC, Jerums G, Comper WD, Osicka TM. The effect of ramipril on albumin excretion in diabetes and hypertension: the role of increased lysosomal activity and decreased transforming growth factor-beta expression. J Hypertens 2003;21:419-428. (Pubitemid 36269715)
42. Russo LM, Osicka TM, Bonnet F, Jerums G, Comper WD. Albuminuria in hypertension is linked to altered lysosomal activity and TGF-beta1 expression. Hypertension 2002;39:281-286. (Pubitemid 34165229)
43. Ling H, Vamvakas S, Busch G, Dämmrich J, Schramm L, Lang F et al. Suppressing role of transforming growth factor-beta 1 on cathepsin activity in cultured kidney tubule cells. Am J Physiol 1995;269:F911-F917.
44. Schenk O, Ling H, Sebeková K, Vamvakas S, Heidland A. Highglucose media enhance the responsiveness of tubular cells to growth promoters: effect on lysosomal cathepsins and protein degradation. Miner Electrolyte Metab 1998;24:254-260. (Pubitemid 28108262)
45. Gekle M, Knaus P, Nielsen R, Mildenberger S, Freudinger R, Wohlfarth V et al. Transforming growth factor-beta1 reduces megalin-and cubilin-mediated endocytosis of albumin in proximal-tubule-derived opossum kidney cells. J Physiol (Lond) 2003;552:471-481. (Pubitemid 37321845)
46. Russo LM, del Re E, Brown D, Lin HY. Evidence for a role of transforming growth factor (TGF)-beta1 in the induction of postglomerular albuminuria in diabetic nephropathy: amelioration by soluble TGF-beta type II receptor. Diabetes 2007;56:380-388.
47. Brooks WW, Bing OH, Robinson KG, Slawsky MT, Chaletsky DM, Conrad CH. Effect of angiotensin-converting enzyme inhibition on myocardial fibrosis and function in hypertrophied and failing myocardium from the spontaneously hypertensive rat. Circulation 1997;96:4002-4010.
48. Brilla CG, Janicki JS, Weber KT. Cardioreparative effects of lisinopril in rats with genetic hypertension and left ventricular hypertrophy. Circulation 1991;83:1771-1779.
49. Terawaki H, Yoshimura K, Hasegawa T, Matsuyama Y, Negawa T, Yamada K et al. Oxidative stress is enhanced in correlation with renal dysfunction: examination with the redox state of albumin. Kidney Int 2004;66:1988-1993.
50. Candiano G, Musante L, Petretto A, Bruschi M, Santucci L, Urbani A et al. Proteomics of plasma and urine in primary nephrotic syndrome in children. Contrib Nephrol 2008;160: 17-28.
51. Hellin JL, Bech-Serra JJ, Moctezuma EL, Chocron S, Santin S, Madrid A et al. Very low-molecular-mass fragments of albumin in the plasma of patients with focal segmental glomerulosclerosis. Am J Kidney Dis 2009;54:871-880.
52. Cochran A, Dong L, Edelman LS, Roberts WL, Ballard J, Privette A et al. Microalbuminuria in acute burn injury. J Burn Care Res 2008;29:176-179.
53. Sviridov D, Owen WE, Roberts WL, Edelman LS, Drake SK, Hortin GL. Proteinuria without albuminuria: urinary protein excretion by a subset of patients with burn injuries. Clin Chim Acta 2009;403: 42-46.
54. Markó L, Szigeti N, Szabó Z, Böddi K, Takátsy A, Ludány A et al. Potential urinary biomarkers of disease activity in Crohn's disease. Scand J Gastroenterol 2010;45:1440-1448.
55. Mahmud N, McDonald GS, Kelleher D, Weir DG. Microalbuminuria correlates with intestinal histopathological grading in patients with inflammatory bowel disease. Gut 1996;38:99-103. (Pubitemid 26020935)
56. Mahmud N, O'Connell MA, Stinson J, Goggins MG, Weir DG, Kelleher D. Tumour necrosis factor-alpha and microalbuminuria in patients with inflammatory bowel disease. Eur J Gastroenterol Hepatol 1995;7:215-219.
57. Sakata S, Atassi MZ. Immunochemistry of serum albumin. X. Five major antigenic sites of human serum albumin are extrapolated from bovine albumin and confirmed by synthetic peptides. Mol Immunol 1980;17:139-142. (Pubitemid 10211825)
58. Brinkman JW, Bakker SJ, Gansevoort RT, Hillege HL, Kema IP, Gans RO et al. Which method for quantifying urinary albumin excretion gives what outcome? A comparison of immunonephelometry with HPLC. Kidney Int Suppl 2004;S69-S75. (Pubitemid 43361437)
59. Markó L, Molnár GA, Wagner Z, Böddi K, Koszegi T, Szabó Z et al. Measurement of the modification and interference rate of urinary albumin detected by size-exclusion HPLC. Physiol Meas 2009;30:1137-1150.
60. Brinkman JW, de Zeeuw D, Duker JJ, Gansevoort RT, Kema IP, Hillege HL et al. Falsely low urinary albumin concentrations after prolonged frozen storage of urine samples. Clin Chem 2005;51:2181-2183. (Pubitemid 41532643)
61. Osicka TM, Comper WD. Characterization of immunochemically nonreactive urinary albumin. Clin Chem 2004;50:2286-2291. (Pubitemid 39552163)
62. Bertolatus JA, Hunsicker LG. Glomerular sieving of anionic and neutral bovine albumins in proteinuric rats. Kidney Int 1985;28:467-476. (Pubitemid 15248036)
63. Greive KA, Eppel GA, Reeve S, Smith AI, Jerums G, Comper WD. Immuno-unreactive albumin excretion increases in streptozotocin diabetic rats. Am J Kidney Dis 2001;38:144-152. (Pubitemid 32611771)
64. Comper WD, Jerums G, Osicka TM. Differences in urinary albumin detected by four immunoassays and high-performance liquid chromatography. Clin Biochem 2004;37:105-111. (Pubitemid 38077160)
65. Osicka TM, MacIsaac RJ, Jerums G, Comper WD. High prevalence of immunounreactive albumin in urine from diabetic patients with a low glomerular filtration rate and normoalbuminuria. Diabetes Care 2004;27:1515. (Pubitemid 38680005)
66. Comper WD, Osicka TM, Clark M, MacIsaac RJ, Jerums G. Earlier detection of microalbuminuria in diabetic patients using a new urinary albumin assay. Kidney Int 2004;65:1850-1855. (Pubitemid 38591035)
67. Markó L, Cseh J, Kószegi T, Szabó Z, Molnár GA, Mohás M et al. Storage at-80 degrees C decreases the concentration of HPLCdetected urinary albumin: possible mechanisms and implications. J Nephrol 2009;22:397-402.
68. Brinkman JW, de Zeeuw D, Lambers Heerspink HJ, Gansevoort RT, Kema IP, de Jong PE et al. Apparent loss of urinary albumin during long-term frozen storage: HPLC vs immunonephelometry. Clin Chem 2007;53:1520-1526. (Pubitemid 47206350)
69. Singh R, Crow FW, Babic N, Lutz WH, Lieske JC, Larson TS et al. A liquid chromatography-mass spectrometry method for the quantification of urinary albumin using a novel 15N-isotopically labeled albumin internal standard. Clin Chem 2007;53:540-542. (Pubitemid 46447959)
70. Babic N, Larson TS, Grebe SK, Turner ST, Kumar R, Singh RJ. Application of liquid chromatography-mass spectrometry technology for early detection of microalbuminuria in patients with kidney disease. Clin Chem 2006;52:2155-2157.
71. Shaikh A, Seegmiller JC, Borland TM, Burns BE, Ladwig PM, Singh RJ et al. Comparison between immunoturbidimetry, size-exclusion chromatography, and LC-MS to quantify urinary albumin. Clin Chem 2008;54:1504-1510.
72. Seegmiller JC, Barnidge DR, Burns BE, Larson TS, Lieske JC, Kumar R. Quantification of urinary albumin by using protein cleavage and LC-MS/MS. Clin Chem 2009;55:1100-1107.
73. Whicher JT, Ritchie RF, Johnson AM, Baudner S, Bienvenu J, Blirup-Jensen S et al. New international reference preparation for proteins in human serum (RPPHS). Clin Chem 1994;40:934-938. (Pubitemid 24166313)
74. Zegers I, Keller T, Schreiber W, Sheldon J, Albertini R, Blirup-Jensen S et al. Characterization of the new serum protein reference material ERM-DA470k/IFCC: value assignment by immunoassay. Clin Chem 2010;56:1880-1888.
75. Comper WD, Jerums G, Osicka TM. Differences in urinary albumin detected by four immunoassays and high-performance liquid chromatography. Clin Biochem 2004;37:105-111. (Pubitemid 38077160)
76. Giampietro O, Penno G, Clerico A, Cruschelli L, Lucchetti A, Nannipieri M et al. Which method for quantifying "microalbuminuria" in diabetics? Comparison of several immunological methods (immunoturbidimetric assay, immunonephelometric assay, radioimmunoassay and two semiquantitative tests) for measurement of albumin in urine. Acta Diabetol 1992;28:239-245.
77. Roberts WL, Calcote CB, Cook CB, Gordon DL, Moore ML, Moore S et al. Comparison of four commercial urinary albumin (microalbumin) methods: implications for detecting diabetic nephropathy using random urine specimens. Clin Chim Acta 1998;273:21-33. (Pubitemid 29044052)
78. Agarwal R. On the nature of proteinuria with acute renal injury in patients with chronic kidney disease. Am J Physiol Renal Physiol 2005;288:F265-F271. (Pubitemid 40105384)
79. Curry S, Mandelkow H, Brick P, Franks N. Crystal structure of human serum albumin complexed with fatty acid reveals an asymmetric distribution of binding sites. Nat Struct Biol 1998;5:827-835. (Pubitemid 28402087)
80. Sviridov D, Meilinger B, Drake SK, Hoehn GT, Hortin GL. Coelution of other proteins with albumin during size-exclusion HPLC: Implications for analysis of urinary albumin. Clin Chem 2006;52:389-397.
81. Clavant SP, Sastra SA, Osicka TM, Comper WD. The analysis and characterisation of immuno-unreactive urinary albumin in healthy volunteers. Clin Biochem 2006;39:143-151. (Pubitemid 43255503)
82. Bakker SJ, Gansevoort RT, de Zeeuw D. Albuminuria: what can we expect from the determination of nonimmunoreactive albumin? Curr Hypertens Rep 2009;11:111-117.
83. Magliano DJ, Polkinghorne KR, Barr EL, Su Q, Chadban SJ, Zimmet PZ et al. HPLC-detected albuminuria predicts mortality. J Am Soc Nephrol 2007;18:3171-3176. (Pubitemid 350223977)
84. McQueen MJ, Gerstein HC, Pogue J, Mann JF, Yusuf S. Reevaluation by high-performance liquid chromatography: clinical significance of microalbuminuria in individuals at high risk of cardiovascular disease in the Heart Outcomes Prevention Evaluation (HOPE) Study. Am J Kidney Dis 2006;48:889-896. (Pubitemid 44895374)
85. Wang Z, Hoy WE, Nicol JL, Wang Z, Su Q, Atkins RC et al. Predictive value of nephelometric and high-performance liquid chromatography assays of urine albumin for mortality in a high-risk Aboriginal population. Am J Kidney Dis 2008;52:672-682.
86. Halimi JM, Buchler M, Al-Najjar A, Laouad I, Chatelet V, Marlière JF et al. Urinary albumin excretion and the risk of graft loss and death in proteinuric and non-proteinuric renal transplant recipients. Am J Transplant 2007;7:618-625. (Pubitemid 46376448)
87. Caramori ML, Fioretto P, Mauer M. The need for early predictors of diabetic nephropathy risk: is albumin excretion rate sufficient? Diabetes 2000;49:1399-1408.
88. Fioretto P, Steffes MW, Sutherland DE, Mauer M. Sequential renal biopsies in insulin-dependent diabetic patients: structural factors associated with clinical progression. Kidney Int 1995;48:1929-1935.